Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SCOR in Targeted Therapies for Infant Leukemia Project 3: Targeting FLT3 in Infant Leukemia

NCT01150669 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01150669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01150669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SCOR in Targeted Therapies for Infant Leukemia Project 3: Targeting FLT3 in Infant Leukemia
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
July 31, 2010
Completion date
May 31, 2016
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

childhood acute lymphoblastic leukemia, childhood acute myeloid leukemia/other myeloid malignancies